In summary, we demonstrate an intimate co-regulatory network between C19MC, p53, and MAGEAs in HCC, where C19MC miRNA overexpression and p53 deficiency modulate MAGEA expression, cellular transformation and cell survival pathways. The gene discussed is TP53; the disease is hepatocellular carcinoma.